Latest news and press releases about PetMed Express, Inc. (PETS): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines.
Price
| Price | $1.60 |
| Market Cap | $34M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 1.48 |
| EV / EBITDA | -1.01 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -108.76% |
| Return on Invested Capital | -130.21% |
| Return on Assets | -45.92% |
| Gross Margin | 23.71% |
| Operating Margin | -18.22% |
| Net Margin | -17.34% |
Related companies: BDSX · CTSO · FBIO · GNTA · ICCM · MDAI · MDCX
Explore sector: Consumer Cyclical · Specialty Retail
More sections of PETS: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks